Advances in contraception: new options for postpartum women

Rebecca L. Taub, Jeffrey Jensen

Research output: Contribution to journalReview article

2 Citations (Scopus)

Abstract

Introduction: short interval repeat pregnancy increases maternal and neonatal morbidity, and provision of postpartum contraception provides primary protection against these adverse outcomes. Confusion regarding effects on breast feeding and thrombosis risk delaying initiation of contraception in the immediate post-partum interval. Delaying contraception provision until the 6-week postpartum visit misses many women who either do not attend or have resumed ovulation and/or intercourse prior to this visit. Because of this, recent studies have looked into initiation of highly effective contraceptive methods at earlier intervals including immediately postpartum. These data provide strong evidence for immediate post-partum initiation of the most effective long-acting reversible contraception (LARC) methods, intrauterine devices and implants. Areas covered: We review the data for safety and efficacy, timing of initiation, and continuation rates of various contraceptive methods in the postpartum period. We also evaluate effects on initiation and continuation of breastfeeding for each contraceptive method discussed. Expert opinion: It is important to counsel patients antenatally regarding the full spectrum of contraceptive options available with a focus on long-acting reversible contraceptive (LARC) methods. When a woman chooses a LARC method, her provider should consider placement in the immediate postpartum period.

Original languageEnglish (US)
Pages (from-to)677-688
Number of pages12
JournalExpert Opinion on Pharmacotherapy
Volume18
Issue number7
DOIs
StatePublished - May 3 2017

Fingerprint

Contraception
Postpartum Period
Breast Feeding
Birth Intervals
Intrauterine Devices
Expert Testimony
Contraceptive Agents
Ovulation
Thrombosis
Mothers
Morbidity
Safety

Keywords

  • breastfeeding
  • LARC
  • Postpartum contraception

ASJC Scopus subject areas

  • Pharmacology
  • Pharmacology (medical)

Cite this

Advances in contraception : new options for postpartum women. / Taub, Rebecca L.; Jensen, Jeffrey.

In: Expert Opinion on Pharmacotherapy, Vol. 18, No. 7, 03.05.2017, p. 677-688.

Research output: Contribution to journalReview article

@article{4013e891200b4c108e46f6b68fb92d4f,
title = "Advances in contraception: new options for postpartum women",
abstract = "Introduction: short interval repeat pregnancy increases maternal and neonatal morbidity, and provision of postpartum contraception provides primary protection against these adverse outcomes. Confusion regarding effects on breast feeding and thrombosis risk delaying initiation of contraception in the immediate post-partum interval. Delaying contraception provision until the 6-week postpartum visit misses many women who either do not attend or have resumed ovulation and/or intercourse prior to this visit. Because of this, recent studies have looked into initiation of highly effective contraceptive methods at earlier intervals including immediately postpartum. These data provide strong evidence for immediate post-partum initiation of the most effective long-acting reversible contraception (LARC) methods, intrauterine devices and implants. Areas covered: We review the data for safety and efficacy, timing of initiation, and continuation rates of various contraceptive methods in the postpartum period. We also evaluate effects on initiation and continuation of breastfeeding for each contraceptive method discussed. Expert opinion: It is important to counsel patients antenatally regarding the full spectrum of contraceptive options available with a focus on long-acting reversible contraceptive (LARC) methods. When a woman chooses a LARC method, her provider should consider placement in the immediate postpartum period.",
keywords = "breastfeeding, LARC, Postpartum contraception",
author = "Taub, {Rebecca L.} and Jeffrey Jensen",
year = "2017",
month = "5",
day = "3",
doi = "10.1080/14656566.2017.1316370",
language = "English (US)",
volume = "18",
pages = "677--688",
journal = "Expert Opinion on Pharmacotherapy",
issn = "1465-6566",
publisher = "Informa Healthcare",
number = "7",

}

TY - JOUR

T1 - Advances in contraception

T2 - new options for postpartum women

AU - Taub, Rebecca L.

AU - Jensen, Jeffrey

PY - 2017/5/3

Y1 - 2017/5/3

N2 - Introduction: short interval repeat pregnancy increases maternal and neonatal morbidity, and provision of postpartum contraception provides primary protection against these adverse outcomes. Confusion regarding effects on breast feeding and thrombosis risk delaying initiation of contraception in the immediate post-partum interval. Delaying contraception provision until the 6-week postpartum visit misses many women who either do not attend or have resumed ovulation and/or intercourse prior to this visit. Because of this, recent studies have looked into initiation of highly effective contraceptive methods at earlier intervals including immediately postpartum. These data provide strong evidence for immediate post-partum initiation of the most effective long-acting reversible contraception (LARC) methods, intrauterine devices and implants. Areas covered: We review the data for safety and efficacy, timing of initiation, and continuation rates of various contraceptive methods in the postpartum period. We also evaluate effects on initiation and continuation of breastfeeding for each contraceptive method discussed. Expert opinion: It is important to counsel patients antenatally regarding the full spectrum of contraceptive options available with a focus on long-acting reversible contraceptive (LARC) methods. When a woman chooses a LARC method, her provider should consider placement in the immediate postpartum period.

AB - Introduction: short interval repeat pregnancy increases maternal and neonatal morbidity, and provision of postpartum contraception provides primary protection against these adverse outcomes. Confusion regarding effects on breast feeding and thrombosis risk delaying initiation of contraception in the immediate post-partum interval. Delaying contraception provision until the 6-week postpartum visit misses many women who either do not attend or have resumed ovulation and/or intercourse prior to this visit. Because of this, recent studies have looked into initiation of highly effective contraceptive methods at earlier intervals including immediately postpartum. These data provide strong evidence for immediate post-partum initiation of the most effective long-acting reversible contraception (LARC) methods, intrauterine devices and implants. Areas covered: We review the data for safety and efficacy, timing of initiation, and continuation rates of various contraceptive methods in the postpartum period. We also evaluate effects on initiation and continuation of breastfeeding for each contraceptive method discussed. Expert opinion: It is important to counsel patients antenatally regarding the full spectrum of contraceptive options available with a focus on long-acting reversible contraceptive (LARC) methods. When a woman chooses a LARC method, her provider should consider placement in the immediate postpartum period.

KW - breastfeeding

KW - LARC

KW - Postpartum contraception

UR - http://www.scopus.com/inward/record.url?scp=85018867260&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85018867260&partnerID=8YFLogxK

U2 - 10.1080/14656566.2017.1316370

DO - 10.1080/14656566.2017.1316370

M3 - Review article

C2 - 28375776

AN - SCOPUS:85018867260

VL - 18

SP - 677

EP - 688

JO - Expert Opinion on Pharmacotherapy

JF - Expert Opinion on Pharmacotherapy

SN - 1465-6566

IS - 7

ER -